Stay updated with breaking news from Confluence Pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Significant breakthroughs in the rapid and cost-effective analysis of the human genome have brought clarity to the path of discovering the...
DelveInsight's, Fragile X Syndrome Pipeline Insight 2023 report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in the Fragile X Syndrome pipeline landscape. It covers the...
/PRNewswire/ -- The "Global Genetic Disorders Partnering 2016-2023: Deal trends, players and financials" report has been added to ResearchAndMarkets.com's...
The changing dynamics of the Argininosuccinic aciduria market, Complement 3 glomerulopathy market, Dup15q syndrome market, Fragile X syndrome market, and Neurofibromatosis Type-2 (NF2) market: Analysis by DelveInsight Complement 3 glomerulopathy market landscape Dup15q syndrome Market Dup15q syndrome is a neurogenetic disorder that results from duplications of chromosome 15q11.2-13.1. It is characterized by hypotonia, developmental delay and intellectual disability (ID), epilepsy, and autism spectrum disorder (ASD). Children with 15q11-q13 duplications are at high risk for neurodevelopmental ...